SPARC
SPARC
Also known as: BM-40, ON, ONT, SPRC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09486
- Gene
- SPARC
- Ensembl
- ENSG00000113140
- Chromosome
- 5
- Canonical length
- 303 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]
Canonical amino-acid sequenceUniProt
303 residues, UniProt reviewed canonical sequence.
>P09486|SPARC
1 MRAWIFFLLC LAGRALAAPQ QEALPDETEV VEETVAEVTE VSVGANPVQV EVGEFDDGAE
61 ETEEEVVAEN PCQNHHCKHG KVCELDENNT PMCVCQDPTS CPAPIGEFEK VCSNDNKTFD
121 SSCHFFATKC TLEGTKKGHK LHLDYIGPCK YIPPCLDSEL TEFPLRMRDW LKNVLVTLYE
181 RDEDNNLLTE KQKLRVKKIH ENEKRLEAGD HPVELLARDF EKNYNMYIFP VHWQFGQLDQ
241 HPIDGYLSHT ELAPLRAPLI PMEHCTTRFF ETCDLDNDKY IALDEWAGCF GIKQKDIDKD
301 LVILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPARC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 2,047 nTPM
Expression across tissuesHPA
Tissue
- placenta: 2,047 nTPM
- adipose tissue: 1,559 nTPM
- ovary: 1,492 nTPM
- gallbladder: 1,426 nTPM
- blood vessel: 1,378 nTPM
- smooth muscle: 1,167 nTPM
Single-cell type
- hepatic stellate cells: 3,983 nCPM
- platelets: 2,264 nCPM
- decidual stromal cells: 1,466 nCPM
- peritubular myoid cells: 1,058 nCPM
- pericytes: 992 nCPM
- endometrial stromal cells: 974 nCPM
Immune cell
- total PBMC: 124 nTPM
- neutrophil: 25 nTPM
- basophil: 10 nTPM
- classical monocyte: 8.7 nTPM
- eosinophil: 2.7 nTPM
- myeloid DC: 2.3 nTPM
Brain region
- hypothalamus: 3,295 nTPM
- medulla oblongata: 2,846 nTPM
- midbrain: 2,637 nTPM
- pons: 2,251 nTPM
- white matter: 2,208 nTPM
- thalamus: 2,168 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SPARC.
Disease | AllUniProt
Conditions SPARC is implicated in, by any mechanism.
- Osteogenesis imperfecta 17 (OI17) MIM:616507
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 271 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Osteogenesis imperfecta type 17
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.89
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of angiogenesis
- negative regulation of endothelial cell proliferation
- positive regulation of endothelial cell migration
- regulation of cell morphogenesis
- regulation of synapse organization
- semicircular canal morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Osteonectin-like, conserved site
- Kazal domain
- Follistatin-like, N-terminal
- EF-hand domain pair
- Follistatin/Osteonectin EGF domain
- EF-Hand 1, calcium-binding site
- SPARC/Testican, calcium-binding domain
- Kazal domain superfamily
- Kazal-type serine protease inhibitor domain
- Follistatin/Osteonectin-like EGF domain
- Secreted protein acidic and rich in cysteine Ca binding region
- SPARC, follistatin-like domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPARC as an antibody target. Whether an autoantibody or antibody against SPARC could matter depends on whether native SPARC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPARC is annotated as secreted, so native SPARC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SPARC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...